![CTLA-4 [Biotinylated] : B7-2 Inhibitor Screening ELISA Kit](/_ipx/q_100,fit_outside,s_360x255/images/no-image-product-box.jpg "CTLA-4 [Biotinylated] : B7-2 Inhibitor Screening ELISA Kit")
![CTLA-4 [Biotinylated] : B7-2 Inhibitor Screening ELISA Kit](/_ipx/_/images/no-image-product-box.jpg "CTLA-4 [Biotinylated] : B7-2 Inhibitor Screening ELISA Kit")
CTLA-4 [Biotinylated] : B7-2 Inhibitor Screening ELISA Kit
1074.92 €
In Stock
quantity
product details
Catalog number: 716 - EP-126
Product Category: Business & Industrial > Science & Laboratory
Gentaur
Size: 96tests
![B7-2 [Biotinylated] : CTLA-4 Inhibitor Screening ELISA Kit](/images/no-image-product-box.jpg "B7-2 [Biotinylated] : CTLA-4 Inhibitor Screening ELISA Kit")
EP-117
B7-2 [Biotinylated] : CTLA-4 Inhibitor Screening ELISA Kit
Cytotoxic T lymphocyte associated ANTIgen-4 (CTLA-4), also known as CD152, is a kind of leukocyte differentiation antigen and a transmembrane receptor on T cells, sharing B7 ligand with CD28. The binding of CTLA-4 with B7 induces T cells to be non-reactive and participates in the negative regulation of immune response. The recombinant CTLA-4 Ig can effectively and specifically inhibit cellular and humoral immune responses in vivo and in vitro, and has significant therapeutic effects on transplant rejection and various autoimmune diseases with very low toxicity. It is considered as a promising new immunosuppressive drug at present.
1074.92 €
EP-117-96tests
B7-2 [Biotinylated] : CTLA-4 Inhibitor Screening ELISA Kit
Cytotoxic T lymphocyte associated ANTIgen-4 (CTLA-4), also known as CD152, is a kind of leukocyte differentiation antigen and a transmembrane receptor on T cells, sharing B7 ligand with CD28. The binding of CTLA-4 with B7 induces T cells to be non-reactive and participates in the negative regulation of immune response. The recombinant CTLA-4 Ig can effectively and specifically inhibit cellular and humoral immune responses in vivo and in vitro, and has significant therapeutic effects on transplant rejection and various autoimmune diseases with very low toxicity. It is considered as a promising new immunosuppressive drug at present.
1074.92 €
EP-126
CTLA-4 [Biotinylated] : B7-2 Inhibitor Screening ELISA Kit
Cytotoxic T lymphocyte associated ANTIgen-4 (CTLA-4), also known as CD152, is a kind of leukocyte differentiation antigen and a transmembrane receptor on T cells, sharing B7 ligand with CD28. The binding of CTLA-4 with B7 induces T cells to be non-reactive and participates in the negative regulation of immune response. The recombinant CTLA-4 Ig can effectively and specifically inhibit cellular and humoral immune responses in vivo and in vitro, and has significant therapeutic effects on transplant rejection and various autoimmune diseases with very low toxicity. It is considered as a promising new immunosuppressive drug at present.
1074.92 €
EP-138
CD47 [Biotinylated] : SIRP alpha Inhibitor Screening ELISA Kit
CD47 is a transmembrane protein, a cell surface glycoprotein molecule belonging to the immunoglobulin superfamily that binds to a variety of proteins, including integrins, thrombospondin 1, and signal regulatory protein-α (SIRPα). In recent years, accumulating data have demonstrated that the CD47-SIRP-α axis is a key immune checkpoint in different cancers, including hematological malignancies, similar to PD-1/PD-L1 in solid tumors. Cd47-sirpα blockade has become a next-generation immune checkpoint blocking strategy for various malignancies after PD-1/PD-L1.
1074.92 €
EP-138-96tests
CD47 [Biotinylated] : SIRP alpha Inhibitor Screening ELISA Kit
CD47 is a transmembrane protein, a cell surface glycoprotein molecule belonging to the immunoglobulin superfamily that binds to a variety of proteins, including integrins, thrombospondin 1, and signal regulatory protein-α (SIRPα). In recent years, accumulating data have demonstrated that the CD47-SIRP-α axis is a key immune checkpoint in different cancers, including hematological malignancies, similar to PD-1/PD-L1 in solid tumors. Cd47-sirpα blockade has become a next-generation immune checkpoint blocking strategy for various malignancies after PD-1/PD-L1.
1074.92 €
EP-143
TNF-alpha [Biotinylated] : TNFR1 Inhibitor Screening ELISA Kit
Tumor Necrosis Factor (TNF), also known as TNFα, is a kind of cytokine that can kill tumor cells directly and has no obvious cytotoxicity to normal cells. TNF is a cell signaling protein involved in systemic inflammation, and it is one of the cytokines that constitute the acute phase response. It is produced primarily by activated macrophages, but most other immune cells, such as CD4+ lymphocytes, NK cells, neutrophils, mast cells, eosinophils, and neurons in the nervous system can also produce it.